GAN & LEE PHARMACEUTICALS. Gan & Lee Pharmaceuticals. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 1,229.77 million compared to CNY 834.8 million a year ago.
Net income was CNY 134.16 million compared to net loss of CNY 197.61 million a year ago. Basic earnings per share from continuing operations was CNY 0.24 compared to basic loss per share from continuing operations of CNY 0.35 a year ago. Diluted earnings per share from continuing operations was CNY 0.24 compared to diluted loss per share from continuing operations of CNY 0.35 a year ago.
